[Skip to Navigation]
Comment & Response
June 17, 2021

Additional Considerations Regarding Timolol Eyedrops for Acute Treatment of Migraine

Author Affiliations
  • 1Independent Researcher, Bathinda, Punjab, India
  • 2Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India
JAMA Ophthalmol. 2021;139(8):920. doi:10.1001/jamaophthalmol.2021.1783

To the Editor We read with interest the article by Kurian et al,1 who used a binary outcome superiority crossover randomized clinical trial to investigate the efficacy of topical timolol for treatment of acute migraine attacks, and the adjoining commentary.2 We wish to bring to the authors’ attention a few points of interest regarding their study.

Add or change institution